Nanotherapeutics with immunoregulatory functions for the treatment of bacterial infection
D Yang, M Ding, Y Song, Y Hu, W Xiu… - Biomaterials …, 2023 - spj.science.org
Biomaterials research, 2023•spj.science.org
The advent of drug-resistant pathogens results in the occurrence of stubborn bacterial
infections that cannot be treated with traditional antibiotics. Antibacterial immunotherapy by
reviving or activating the body's immune system to eliminate pathogenic bacteria has
confirmed promising therapeutic strategies in controlling bacterial infections. Subsequent
studies found that antimicrobial immunotherapy has its own benefits and limitations, such as
avoiding recurrence of infection and autoimmunity-induced side effects. Current studies …
infections that cannot be treated with traditional antibiotics. Antibacterial immunotherapy by
reviving or activating the body's immune system to eliminate pathogenic bacteria has
confirmed promising therapeutic strategies in controlling bacterial infections. Subsequent
studies found that antimicrobial immunotherapy has its own benefits and limitations, such as
avoiding recurrence of infection and autoimmunity-induced side effects. Current studies …
Abstract
The advent of drug-resistant pathogens results in the occurrence of stubborn bacterial infections that cannot be treated with traditional antibiotics. Antibacterial immunotherapy by reviving or activating the body’s immune system to eliminate pathogenic bacteria has confirmed promising therapeutic strategies in controlling bacterial infections. Subsequent studies found that antimicrobial immunotherapy has its own benefits and limitations, such as avoiding recurrence of infection and autoimmunity-induced side effects. Current studies indicate that the various antibacterial therapeutic strategies inducing immune regulation can achieve superior therapeutic efficacy compared with monotherapy alone. Therefore, summarizing the recent advances in nanomedicine with immunomodulatory functions for combating bacterial infections is necessary. Herein, we briefly introduce the crisis caused by drug-resistant bacteria and the opportunity for antibacterial immunotherapy. Then, immune-involved multimodal antibacterial therapy for the treatment of infectious diseases was systematically summarized. Finally, the prospects and challenges of immune-involved combinational therapy are discussed.
Graphical Abstract
![](/scholar/images/qa_favicons/sciencemag.org.png)